Gotowa bibliografia na temat „Experimental trials”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Experimental trials”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Experimental trials"
Bolton, Sanford. "Experimental Design in Clinical Trials". Clinical Research and Regulatory Affairs 17, nr 4 (styczeń 2000): 285–344. http://dx.doi.org/10.3109/10601330009010839.
Pełny tekst źródłaHamilton, E. P., G. H. Lyman, S. Kim i J. Peppercorn. "Availability of experimental therapy outside of randomized clinical trials in oncology". Journal of Clinical Oncology 27, nr 15_suppl (20.05.2009): 6539. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.6539.
Pełny tekst źródłaCicchetti, Americo, Domenico Addesso, Filippo Elvino Leone, Antonino Amato, Luca Angerame, Angelo D'Aversa, Mario Fraticelli i in. "Valorization of clinical trials from the Italian National Health Service perspective: definition and first application of a model to estimate avoided costs". Global & Regional Health Technology Assessment 7, nr 1 (16.06.2020): 26–32. http://dx.doi.org/10.33393/grhta.2020.709.
Pełny tekst źródłaMenefee, Michael E., Yutao Gong, Pallavi Shruti Mishra-Kalyani, Rajeshwari Sridhara, Bindu Kanapuru, Gideon Michael Blumenthal i Richard Pazdur. "Project Switch: Docetaxel as a potential synthetic control in metastatic non-small cell lung cancer (mNSCLC) trials." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): 9105. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.9105.
Pełny tekst źródłaHamilton, Erika P., Gary H. Lyman i Jeffrey Peppercorn. "Availability of Experimental Therapy Outside Oncology Randomized Clinical Trials in the United States". Journal of Clinical Oncology 28, nr 34 (1.12.2010): 5067–73. http://dx.doi.org/10.1200/jco.2010.28.6567.
Pełny tekst źródłaFujinaka, Hidehiko, Masanori Hara, Makoto Uchiyama, Eishin Yaoita, Katsutoshi Kawasaki, Tadashi Yamamoto i Itaru Kihara. "Therapeutic Trials of Experimental Crescentic Glomerulonephritis." Nihon Shoni Jinzobyo Gakkai Zasshi 10, nr 1 (1997): 87–91. http://dx.doi.org/10.3165/jjpn.10.87.
Pełny tekst źródłaSalama, Ragga H., Abd El Rahman G. Ramadan, Tasneem A. Alsanory, Mohammed O. Herdan, Omnia M. Fathallah i Aya A. Alsanory. "Experimental and Therapeutic Trials of Amygdalin". International Journal of Biochemistry and Pharmacology 1, nr 1 (28.10.2019): 21–26. http://dx.doi.org/10.18689/ijbp-1000105.
Pełny tekst źródłaFinkel, R. "Experimental trials in spinal muscular atrophy". Neuromuscular Disorders 27 (marzec 2017): S2. http://dx.doi.org/10.1016/s0960-8966(17)30224-9.
Pełny tekst źródłaGibbs, Lauren. "Rethinking Eligibility for Experimental Clinical Trials". JAMA Neurology 75, nr 1 (1.01.2018): 22. http://dx.doi.org/10.1001/jamaneurol.2017.3492.
Pełny tekst źródłaFast, Patricia E., i Mary Clare Walker. "Human trials of experimental AIDS vaccines". AIDS 7 (styczeń 1992): S147—S160. http://dx.doi.org/10.1097/00002030-199201001-00020.
Pełny tekst źródłaRozprawy doktorskie na temat "Experimental trials"
Matassa, Vincenzo. "Optimisation of experimental design and analysis for sugarcane variety trials /". [St. Lucia, Qld.], 2003. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe17336.pdf.
Pełny tekst źródłaKirvesoja, H. (Heli). "Experimental ergonomic evaluation with user trials: EEE product development procedures". Doctoral thesis, University of Oulu, 2001. http://urn.fi/urn:isbn:9514259378.
Pełny tekst źródłaXu, Bo. "Predictors of treatment means for a one factor completely randomized design". Amherst, Mass. : University of Massachusetts Amherst, 2009. http://scholarworks.umass.edu/dissertations/AAI3372284/.
Pełny tekst źródłaLind, Torbjörn. "Iron and zinc in infancy : results from experimental trials in Sweden and Indonesiaa". Doctoral thesis, Umeå universitet, Epidemiologi och folkhälsovetenskap, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-277.
Pełny tekst źródłaDhaliwal, Lesley. "Research design and effect size : a meta-analysis of mood disorder experimental trials". Thesis, University of British Columbia, 2015. http://hdl.handle.net/2429/54731.
Pełny tekst źródłaEducation, Faculty of
Educational and Counselling Psychology, and Special Education (ECPS), Department of
Graduate
Gatch, Michael B. "An Experimental Analysis of Higher-Order Stimulus Control in Humans". DigitalCommons@USU, 1990. https://digitalcommons.usu.edu/etd/6017.
Pełny tekst źródłaMcBride, Ali. "Evaluating Fast Track Time Analysis of Clinical Drug Trial Phases Utilizing a Quasi-Experimental Observational Study". The University of Arizona, 2007. http://hdl.handle.net/10150/624440.
Pełny tekst źródłaObjectives: In this paper we analyzed the time frame for oncology drugs that were designated as a fast track drug and the time transition from a phase II to phase III clinical trial completion. Methods In our study we utilized oncology drugs that were approved between the years of 2000-2006 (FDA.gov). We then analyzed the CDER data base that provided information to Fast Track drugs that have been approved within the time period as determined by the FDA selection criteria (21 CFR 312.81(a)). Under certain circumstances, the FCA may consider reviewing portions of a marketing application in advance of the complete New Drug Application (NDA) or Biologic License Application (BLA). We will evaluate fast track designated products which may also be eligible to participate in FDA’s Continuous Marketing Applications Pilot 1 or Pilot 2 programs. For our analysis, we specifically selected oncology drugs. In particular, we analyzed 32 drugs from the stated time period. Each fast track drug was then selected and analyzed for its clinical phase development time period based on news announcements during clinical trails. For each announcement we conducted an event study analysis through lexis Nexus with respect to the announcement of a clinical trial enrollment, clinical trials news (Phase I, II, III). Results: The results of our preliminary study show that there was a shorter time to development transition for the fast track oncology drugs. The oncology clinical phase transition from II to three on average lasted 12 months with a range of 2 - 29 months The average length of the phase development had to excludes 4 drugs due to the lack of information provided from the LexisNexis database. The current timeline for fats track drugs has shown a decrease in transition from clinical trials to the market. In the example of Spyrcel, the data from our study had to be excluded, there was a definitive difference in the time to approval process for the drug as compared to other standard review entities. The approvals for dasatinib, or Sprycel, for refractory CML was shown to move through the development to approval in one of the fastest timeframes in modern development. Since its first clinical study on in Gleevec-resistant patients, the medication was decided on entering an accelerated timeline. It took us just 25 months to bring Sprycel from first-in-human dosing to a regulatory submission. In contrast, the industry average for this cycle time is 6.4 years which is three times greater than the cycle time for Sprycel. Conclusions: The new Subpart H regulations state that post-marketing studies to confirm clinical benefit that would consist usually by "studies underway” at the time of accelerated approval, this has not always been the case and is not a requirement (Dagher R, Johnson J, Williams G et al). In conclusion, the accelerated approval program in oncology has been successful in making 18 different products available to patients for 22 different cancer treatment indications since the inception of the fast track program. From the current data and transition information, there is a comparative difference between the clinical phase transitions from phase II to Phase III clinical trials. However, this preliminary data needs to be further evaluated against the standard FDA review process from oncology drugs. Moreover, further studies will be needed to interpret whether the average length of oncology studies biases the value of our study.
Bergh, Anna. "Defocused CO₂ laser irradiation in the rehabilitation of horses : an experimental and clinical study /". Uppsala : Dept. of Anatomy and Physiology, Swedish University of Agricultural Sciences, 2006. http://epsilon.slu.se/200654.pdf.
Pełny tekst źródłaSvensson, Jennie. "An Experimental Study to Improve the Casting Performance of Steel Grades Sensitive for Clogging". Doctoral thesis, KTH, Tillämpad processmetallurgi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-202539.
Pełny tekst źródłaQC 20170227
VINNOVA
Behrel, Morgan. "Investigation of kites for auxiliary ship propulsion : experimental set-up, trials, data analysis and kite specs novel identification approach". Thesis, Brest, 2017. http://www.theses.fr/2017BRES0132.
Pełny tekst źródłaThis study is part of the research program beyond the sea® aiming to develop kites as auxiliary propulsion devices for ships. The goal is to use the energy of the wind to save fuel and reduce harmful emissions. Such a project needs numerous developments and scientific actions, particularly to model the behavior of giant kites and associated ships. However these models must be compared to measurements to assess their validity. This study is then focus on the measurements of the interaction between kites and ships, at a limited scale in comparison to the real scope of the project. Thus measurement campaigns were carried out on a 13-meter long trawler, and on a 6-meter long experimental platform specifically designed. Another experimental campaign was also carried out onshore to assess the aerodynamic specs of the kite. Each of these three campaigns was based on a complex experimental set-up, including an automatic kite control system. In addition to provide a valuable data set for further scientific analyses, this study provided also tools which can be used by the industrial partners of the beyond the sea project®
Książki na temat "Experimental trials"
Beer, Tomasz M. Cancer clinical trials: A commonsense guide to experimental cancer therapies and clinical trials. New York: DiaMedica Pub., 2012.
Znajdź pełny tekst źródłaFinn, Robert. Cancer clinical trials: Experimental treatments & how they can help you. Beijing: O'Reilly, 1999.
Znajdź pełny tekst źródłaFinn, Robert. Cancer clinical trials: Experimental treatments & how they can help you. Beijing: O'Reilly, 1999.
Znajdź pełny tekst źródłaPatel, Shilpesh S. Handbook of cardiovascular clinical trials. New York, NY: Churchill Livingstone, 1997.
Znajdź pełny tekst źródłaRothmann, Mark D. Design and analysis of non-inferiority trials. Boca Raton: Chapman & Hall/CRC, 2011.
Znajdź pełny tekst źródłaWilliams, E. R. Experimental design and analysis for use in tree improvement. East Melbourne, Vic: CSIRO, 1994.
Znajdź pełny tekst źródłaGriffin, J. P. The textbook of pharmaceutical medicine. Wyd. 6. Chichester, West Sussex: Wiley-Blackwell, 2009.
Znajdź pełny tekst źródłaMark, Chang, red. Adaptive design methods in clinical trails. Boca Raton, FL: Chapman & Hall/CRC, 2007.
Znajdź pełny tekst źródłaNational Research Council (U.S.). Committee on National Statistics i National Academies Press (U.S.), red. The prevention and treatment of missing data in clinical trials. Washington, D.C: National Academies Press, 2010.
Znajdź pełny tekst źródłaClinical research and the law. Chichester, West Sussex: John Wiley & Sons, 2012.
Znajdź pełny tekst źródłaCzęści książek na temat "Experimental trials"
McPeek, B., F. Mosteller, M. F. McKneally i E. A. M. Neugebauer. "Experimental Methods: Clinical Trials". W Principles and Practice of Research, 114–25. New York, NY: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4684-0371-8_14.
Pełny tekst źródłaHolmes, Laurens. "Clinical trials (human experimental designs)". W Applied Epidemiologic Principles and Concepts, 205–26. Abingdon, Oxon ; New York, NY : Routledge, 2018.: CRC Press, 2017. http://dx.doi.org/10.1201/9781315369761-13.
Pełny tekst źródłaDellin, Christopher M., Kyle Strabala, G. Clark Haynes, David Stager i Siddhartha S. Srinivasa. "Guided Manipulation Planning at the DARPA Robotics Challenge Trials". W Experimental Robotics, 149–63. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-23778-7_11.
Pełny tekst źródłaTurner, J. Rick. "Conducting Clinical Trials I: Experimental Methodology". W New Drug Development, 69–78. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6418-2_6.
Pełny tekst źródłaKurosaki, Takashi. "Experimental Design for Flexible Microcredit Trials". W Seasonality and Microcredit, 55–70. Tokyo: Springer Japan, 2014. http://dx.doi.org/10.1007/978-4-431-55010-5_5.
Pełny tekst źródłaAbelson, M. B., G. W. Ousler, L. A. Nally i T. B. Emory. "Dry Eye Syndromes: Diagnosis, Clinical Trials and Pharmaceutical Treatment-‘Improving Clinical Trials’". W Advances in Experimental Medicine and Biology, 1079–86. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0717-8_152.
Pełny tekst źródłaDezawa, Mari. "Clinical Trials of Muse Cells". W Advances in Experimental Medicine and Biology, 305–7. Tokyo: Springer Japan, 2018. http://dx.doi.org/10.1007/978-4-431-56847-6_17.
Pełny tekst źródłaRoss, Allan M. "Implications of the TIMI Trials". W Advances in Experimental Medicine and Biology, 361–66. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4615-3806-6_37.
Pełny tekst źródłaCoates, Anthony R. M., i Gerry Halls. "Antibiotics in Phase II and III Clinical Trials". W Handbook of Experimental Pharmacology, 167–83. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28951-4_11.
Pełny tekst źródłaRobins, H. Ian, i Justin D. Cohen. "Radiant Heat Systemic Hyperthermia Clinical Trials". W Advances in Experimental Medicine and Biology, 189–96. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4684-5766-7_17.
Pełny tekst źródłaStreszczenia konferencji na temat "Experimental trials"
Suyama, Satoshi, Jun Mashino, Yoshihisa Kishiyama i Yukihiko Okumura. "5G multi-antenna technology and experimental trials". W 2016 IEEE International Conference on Communication Systems (ICCS). IEEE, 2016. http://dx.doi.org/10.1109/iccs.2016.7833602.
Pełny tekst źródłaFeoktistov, Vitaliy, Stephane Pietravalle i Nicolas Heslot. "Optimal experimental design of field trials using Differential Evolution". W 2017 IEEE Congress on Evolutionary Computation (CEC). IEEE, 2017. http://dx.doi.org/10.1109/cec.2017.7969505.
Pełny tekst źródłaMalanowski, M., K. Kulpa, P. Samczynski, J. Misiurewicz, J. Kulpa, P. Roszkowski, P. Dzwonkowski i in. "Experimental results of the PaRaDe passive radar field trials". W 2012 13th International Radar Symposium (IRS). IEEE, 2012. http://dx.doi.org/10.1109/irs.2012.6233290.
Pełny tekst źródłaBenjebbour, Anass, i Yoshihisa Kishiyama. "Combination of NOMA and MIMO: Concept and Experimental Trials". W 2018 25th International Conference on Telecommunications (ICT). IEEE, 2018. http://dx.doi.org/10.1109/ict.2018.8464916.
Pełny tekst źródłaZhu, Liyao, Wenbiao Wang, Zhicheng Tao, Bangchu Yang, Zhipei Chen, Han Ge i Guanjun Bao. "Full-Drive Decoupled Bionic Finger: Structure and Experimental Trials*". W 2019 IEEE International Conference on Robotics and Biomimetics (ROBIO). IEEE, 2019. http://dx.doi.org/10.1109/robio49542.2019.8961507.
Pełny tekst źródłaMonteiro, Vítor, J. G. Pinto, J. C. Aparício Fernandes i João L. Afonso. "Experimental Comparison of Single-Phase Active Rectifiers for EV Battery Chargers". W Special Session on Sustainable mobility solutions: vehicle and traffic simulation, on-road trials and EV charging. SCITEPRESS - Science and Technology Publications, 2017. http://dx.doi.org/10.5220/0006391804190425.
Pełny tekst źródłaIwabuchi, Masashi, Anass Benjebbour, Yoshihisa Kishiyama, Guangmei Ren, Chen Tang, Tingjian Tian, Liang Gu, Terufumi Takada i Tsuyoshi Kashima. "5G Field Experimental Trials on URLLC Using New Frame Structure". W 2017 IEEE Globecom Workshops (GC Wkshps). IEEE, 2017. http://dx.doi.org/10.1109/glocomw.2017.8269130.
Pełny tekst źródłaKumagai, Shinya, Morihiko Minowa, Tatsuki Okuyama, Jun Mashino, Satoshi Suyama, Yukihiko Okumura, Takaharu Kobayashi i in. "Experimental Trials of 5G Ultra High-Density Distributed Antenna Systems". W 2019 IEEE 90th Vehicular Technology Conference (VTC2019-Fall). IEEE, 2019. http://dx.doi.org/10.1109/vtcfall.2019.8891604.
Pełny tekst źródłaGavrilin, Sergey, i Sverre Steen. "Uncertainty of Sea Trials Results Used for Validation of Ship Manoeuvring Simulation Models". W ASME 2015 34th International Conference on Ocean, Offshore and Arctic Engineering. American Society of Mechanical Engineers, 2015. http://dx.doi.org/10.1115/omae2015-41887.
Pełny tekst źródłaOctavian, Baltag, i Rau Miuta Carmina. "Experimental trials concerning the simulation of a heart-generated biomagnetic signal". W 2013 8th International Symposium on Advanced Topics in Electrical Engineering (ATEE). IEEE, 2013. http://dx.doi.org/10.1109/atee.2013.6563434.
Pełny tekst źródłaRaporty organizacyjne na temat "Experimental trials"
Ripley, Robert C., i Laura Donahue. Cylindrical Explosive Dispersal of Metal Particles: Predictive Calculations in SUpport of Experimental Trials. Fort Belvoir, VA: Defense Technical Information Center, grudzień 2007. http://dx.doi.org/10.21236/ada505351.
Pełny tekst źródłaCamenzind, Lauren, Molly Kafader, Rachel Schwam, Mikayla Taylor, Zoie Wilkes i Madison Williams. Space Retrieval Training for Memory Enhancement in Adults with Dementia. University of Tennessee Health Science Center, maj 2021. http://dx.doi.org/10.21007/chp.mot2.2021.0013.
Pełny tekst źródłaHernández, Karla, Bridget Lynn Hoffmann, Cristóbal Ruiz-Tagle i Alejandra Schueftan. The Cost-Effectiveness of Air Pollution Information Provision Programs. Inter-American Development Bank, lipiec 2021. http://dx.doi.org/10.18235/0003391.
Pełny tekst źródłaBracht, Juergen. Trial of the Exeter Economic Experiments. Bristol, UK: The Economics Network, styczeń 2010. http://dx.doi.org/10.53593/n985a.
Pełny tekst źródłaMasset, Edoardo. Combining economic modelling and randomised controlled trials: An unexploited synergyCombining economic modelling and randomised controlled trials: An unexploited synergy. Redaktor Radhika Menon. Centre of Excellence for Development Impact and Learning (CEDIL), 2021. http://dx.doi.org/10.51744/cmb3.
Pełny tekst źródłaChassang, Sylvain, Gerard Padro Miquel i Erik Snowberg. Selective Trials: A Principal-Agent Approach to Randomized Controlled Experiments. Cambridge, MA: National Bureau of Economic Research, wrzesień 2010. http://dx.doi.org/10.3386/w16343.
Pełny tekst źródłaMcPhedran, R., K. Patel, B. Toombs, P. Menon, M. Patel, J. Disson, K. Porter, A. John i A. Rayner. Food allergen communication in businesses feasibility trial. Food Standards Agency, marzec 2021. http://dx.doi.org/10.46756/sci.fsa.tpf160.
Pełny tekst źródłaAfzal, Uzma, Giovanna D'Adda, Marcel Fafchamps i Farah Said. Intrahousehold Consumption Allocation and Demand for Agency: A Triple Experimental Investigation. Cambridge, MA: National Bureau of Economic Research, sierpień 2018. http://dx.doi.org/10.3386/w24977.
Pełny tekst źródłaKowalski, Amanda. A model of a randomized experiment with an application to the PROWESS clinical trial. The IFS, marzec 2019. http://dx.doi.org/10.1920/wp.cem.2019.11.
Pełny tekst źródłaKowalski, Amanda. A model of a randomized experiment with an application to the PROWESS clinical trial. The IFS, marzec 2019. http://dx.doi.org/10.1920/wp.cem.2019.1119.
Pełny tekst źródła